Refocus
1 known investors
Refocus Group develops the VisAbility Micro Insert System, an investigational medical device for near vision correction aimed at patients with presbyopia who rely on reading glasses. The device is intended to improve near vision and reduce dependence on reading glasses.
Investors · 1
In the news
Frequently asked questions
- What does Refocus do?
- Refocus Group develops the VisAbility Micro Insert System, an investigational medical device for near vision correction aimed at patients with presbyopia who rely on reading glasses. The device is intended to improve near vision and reduce dependence on reading glasses.
- Who are Refocus's investors?
- Refocus's investors include WP Global Partners.